Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict...
15 insider purchases on record · latest filing 2026-09-11.
Insiders have also filed 134 sale transactions at TYRA.